indomethacin coronavirus

With years of experience and a broad portfolio of past studies on SARS-CoV and MERS-CoV, Creative Biolabs has cultivated solid expertise in the fields of virology and epidemiology. At present, our virologists have obtained enough evidence to speculate that an anti-inflammatory drug, indomethacin (INDO), has great potential and is expected to be the next drug candidate for SARS-CoV-2.